On Thursday, Shares of Kinder Morgan Inc (NYSE:KMI), gained 1.55% to $28.11.
Kinder Morgan, declared that its partner, Tennessee Gas Pipeline Company (TGP), has executed agreements with producers, local distribution companies (LDCs) and a New York end-use market participant totaling 627,000 dekatherms per day (Dth/d) for the Supply Path component of the projected Northeast Energy Direct Project (NED). The agreements will provide a direct supply link from abundant natural gas fields in Pennsylvania to existing and future Northeast and New England markets, and firm transport of incremental supplies for delivery at or near Wright, New York. From the Wright area, shippers can deliver into the Market Path component of the NED project for transport to Dracut, Massachusetts, or into TGP’s existing pipeline system or into the Iroquois Gas Transmission system. The incremental gas supplies will assist meet New York and New England’s growing consumer and industrial gas needs, in addition to assisting to bolster electric reliability in the region. TGP is ongoing to negotiate with additional potential shippers on the NED project, counting LDCs and others, and anticipates to declare these commitments and others at a later date.
NED’s Supply Path component, from northeastern Pennsylvania to Wright, New York, is scalable up to 1.2 billion cubic feet per day (Bcf/d), and its Market Path component is scalable up to 1.3 Bcf/d. The NED project, counting the Supply Path and Market Path components, has a planned in-service date of November 2018, subject to regulatory approvals. Additionally, the NED Supply Path component and associated agreements are subject to approval by the Kinder Morgan board of directors.
Kinder Morgan, Inc. (KMI) is an energy infrastructure and energy company in North America. The Company operates through six segments: Natural Gas Pipelines, CO2, Terminals, Products Pipelines, Kinder Morgan Canada and Other. The Natural Gas Pipelines segment comprises interstate and intrastate pipelines and its liquefied natural gas (LNG) terminals.
Shares of NVIDIA Corporation (NASDAQ:NVDA), declined -1.95% to $24.17, during its last trading session.
NVIDIA Corporation, declared that Microsoft will offer NVIDIA® GPU-enabled professional graphics applications and accelerated computing capabilities to customers worldwide through its cloud platform, Microsoft Azure.
Deploying the latest version of NVIDIA GRID™ in its new N-Series virtual machine offering, Azure is the first cloud computing platform to provide NVIDIA GRID 2.0 virtualized graphics for enterprise customers.
For the first time, businesses will have the ability to deploy NVIDIA Quadro®-grade professional graphics applications and accelerated computing on-premises, in the cloud through Azure, or via a hybrid of the two using both Windows and Linux virtual machines. Azure will also offer customers supercomputing-class performance, with the addition of the NVIDIA Tesla® Accelerated Computing Platform’s flagship Tesla K80 GPU accelerators, for the most computationally demanding data center and high performance computing (HPC) applications.
NVIDIA Corporation (NVIDIA) is engaged in visual computing, enabling individuals to interact with digital ideas, data and entertainment. The Company is engaged in creating NVIDIA-branded products and services, offering its processors to original equipment manufacturers (OEMs), and licensing its intellectual property. NVIDIA-branded products and services are visual computing platforms that address four markets: Gaming, Enterprise, High Performance Computing & Cloud, and Automotive.
Shares of Celgene Corporation (NASDAQ:CELG), inclined 4.34% to $112.86, during its last trading session.
Celgene Corporation, will host a conference call and live audio webcast on Thursday, November 5, 2015 at 9 a.m. ET to discuss third quarter of 2015 financial and operational results. The third quarter will comprise the financial and operational results of Receptos Inc. following the August 27, 2015 close of the acquisition.
Celgene Corporation (Celgene), together with its auxiliaries, is an integrated biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.
Finally, Penn West Petroleum Ltd (USA) (NYSE:PWE), ended its last trade with 11.06% gain, and closed at $0.500.
Penn West Petroleum, is happy to declare that it has reached a definitive agreement for the sale of its non-operated 9.5% working interest in the Weyburn Unit in Southeast Saskatchewan for cash consideration of $205 million, subject to closing adjustments customary in transactions of this nature. We intend to use the proceeds from this disposition to reduce our senior debt. Upon the completion of the sale of our Weyburn Unit working interest, we will have raised about $810 million in total proceeds this year through our non-core asset disposition program.
David Dyck, Senior Vice President and Chief Financial Officer of Penn West, commented, “This disposition further demonstrates the continued success of our non-core asset disposition program. With this transaction, we have surpassed our $650 million non-core asset disposition target. We believe that our dispositions this year evidence the quality of our non-core asset base, our ongoing commitment to reduce our debt, and our ability to successfully execute meaningful transactions in a challenging commodity price environment. We will continue to pursue additional non-core asset divestitures in order to further reduce our leverage and we will continue to focus on our core operations.”
Penn West Petroleum Ltd. (Penn West) is a Canada-based senior exploration and production company. The Company operates to explore for, develop and hold interests in oil and natural gas properties and related production infrastructure in the Western Canada sedimentary basin directly and through investments in securities of auxiliaries holding such interests.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
